VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CAHCardinal Health, Inc.
$279.25$65.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CAH logo

Cardinal Health, Inc.

CAH
NYSE · Drug Distributors & Pharmacies
$279.25
At close - Nov 17, 4:00 PM EST - USD
Market Cap$65.4B
P/E35.8x
52W High$286.29
Volume1.8M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2027Q1

Thin-Margin Distribution Model Hinges on Working Capital Timing

Cardinal Health's revenue has swung between roughly negative 4% and positive 22% year over year across the last ten quarters, and its gross margin has stayed in a narrow 3.1% to 4.3% band, suggesting a distribution model with limited pricing power and growth that is largely volume and timing driven rather than…

GrowthMixed
ProfitabilityWeak
ValuationExpensive
TechnicalsStrong
Explore valuation models
MARKET ACTION

CAH price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

12/12 Beats

EPS beat 12 of last 12 quarters

02

Valuation risk

+62% Peers

P/E is 62% above peer median

03

Market leadership

RS 89 · Leader

High momentum (Outperforming 89% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Feb 5
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue and margin performance show volatile top-line growth and a gross margin confined to 3.1% to 4.3%, with operating margin improving to 1.1% in the latest quarter on $753M of operating income, though net margin remains thin at 0.8%.

Analyst Consensus+0.0% target
Buy(33 analysts)
19 Buy14 Hold0 Sell

The Bull Case

Upside Catalysts

Opioid crisis response leadership

Cardinal Health is actively combating opioid misuse in America, reinforcing its role in securing the pharmaceutical supply chain.

Strong revenue growth

Q4 revenue of $64 billion marked an 8.4% beat, with the strongest sequential acceleration in 7 quarters, driven by 32% growth in Specialty Solutions.

Attractive valuation metrics

CAH's trailing P/E of 24.57 and forward P/E of 16.92 suggest potential undervaluation relative to growth prospects.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CAH+36.74%
S&P 500 (^GSPC)+7.21%
1-Year Return
CAH+36.44%
S&P 500 (^GSPC)+10.03%
3-Year Return
CAH+175.99%
S&P 500 (^GSPC)+59.22%
5-Year Return
CAH+481.77%
S&P 500 (^GSPC)+54.52%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
35.8x
Forward P/EExpansion
22.2x
EV/EBITDA80th %ile
19.2x
FCF YieldCash Flow
7.5%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
35.8x
32.9x
75th· Fair
EV/EBITDA
19.2x
17.2x
80th· High
Price/FCF
13.3x
10.5x
80th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue FY26
$254.25B+14.2% YoY
Net income FY26
$1.71B+9.8% YoY
Free cash flow FY26
$4.53B+144.6% YoY
Operating margin FY26
1%+0.0 pts YoY
ROIC (FY26)75.3%
Avg ROIC 5Y1145.8%
ROE (FY26)-
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate12/12 (100%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 5, 2026
$3.26+10.9%
vs $2.94
$67.5B+1.3%
vs $66.7B
Q3 2026
Aug 11, 2026
$2.91+20.2%
vs $2.42
$63.7B-2.3%
vs $65.2B
Q2 2026
Apr 30, 2026
$3.17+13.6%
vs $2.79
$60.9B-1.9%
vs $62.1B
Q1 2026
Feb 5, 2026
$2.63+12.4%
vs $2.34
$65.6B+0.8%
vs $65.1B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Zacks Investment Research·1d ago
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Defense World·1d ago
Banco Santander S.A. Purchases 12,420 Shares of Cardinal Health, Inc. $CAH

Banco Santander S.A. boosted its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 11.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 117,572 shares of the company's stock after buying an additional 12,420 shares during the quarter. Banco Santander

Zacks Investment Research·2d ago
5 Dividend Growth Stocks to Buy as NVDA CEO Resignation Rattles Market

NVIDIA CEO Jensen Huang's resignation and market volatility bring into the spotlight five dividend growth stocks with earnings growth potential.

Zacks Investment Research·2d ago
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Filtered for Cardinal Health, Inc.More Headlines
04

Compare before deciding

Benchmark CAH against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Cardinal Health, Inc. (CAH)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CAH logoCAHCardinal Health, Inc.Current
$279.25$65.4B35.7914.23%0.71%—0.74%
MCK logoMCKMcKesson Corporation
$1091.67$127.4B27.1112.36%1.12%—0.28%
HSIC logoHSICHenry Schein, Inc.
$82.94$9.45B22.174.03%3.07%8.83%—
ACH logoACHAccendra Health, Inc.
$0.09$6.74M-0.01-74.19%-6.72%——
NXST logoNXSTNexstar Media Group, Inc.
$204.95$6.26B17.04-8.47%4.72%16.68%2.69%
JNJ logoJNJJohnson & Johnson
$278.70$670.89B42.406.05%16.2%19.55%1.83%

Compare CAH vs Peers

Cardinal Health, Inc. (CAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MCK

Most directly comparable listed peer for CAH.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare CAH against a more recognizable public peer.

Peer Set

Compare Top 5

vs MCK, HSIC, ACH, NXST

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CAH SEC Filings & Documents

Cardinal Health, Inc. (CAH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 1, 2026·SEC

Material company update

Aug 11, 2026·SEC

Material company update

Aug 11, 2026·SEC

10-K Annual Reports

3
FY 2026

Aug 11, 2026·SEC

FY 2025

Aug 12, 2025·SEC

FY 2024

Aug 14, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2026

Feb 5, 2026·SEC

FY 2025

Oct 30, 2025·SEC

Get notified when CAH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CAH Frequently Asked Questions

Cardinal Health, Inc. (CAH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Cardinal Health, Inc.'s revenue?

Cardinal Health, Inc. (CAH) reported $257.75B in revenue over the trailing twelve months. Revenue was $254.25B in fiscal year 2026. That is 1282% more than the $18.39B of fiscal year 1997.

How fast is Cardinal Health, Inc. growing?

Cardinal Health, Inc. (CAH) grew revenue by 10.0% over the trailing twelve months, compared with the twelve months before.

Is CAH profitable?

Yes. Cardinal Health, Inc. (CAH) earned $1.82B in net income over the trailing twelve months (a 0.7% net margin).

Dividend & Returns
Does CAH pay dividends?

Yes. Cardinal Health, Inc. (CAH) pays a dividend that yields 0.74% at the current price, a small yield.

What is Cardinal Health, Inc.'s free cash flow?

Cardinal Health, Inc. (CAH) generated $4.90B in free cash flow over the trailing twelve months.

What if you invested $1,000 in CAH back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →